Page 29 - book

CinnaGen Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Founded: 1994
HQ Office: No. 34, Sepehr St., Farahzadi Blvd., Shahrake Gharb, Tehran, IRAN.

Plant Location: No. 72, 3 rd. Sq., SiminDasht Industrial Area, Karaj, I.R. IRAN.

Employees: 1091

Company Profile:
Founded in 1994, CinnaGen is a research and manufacturing company. As the pioneering private knowledge-based
firm in the biotechnology sector, our mission is to manufacture cutting-edge biotech products that meet the needs
of patients. Our diverse product line includes biosimilar drugs in therapeutic areas such as Neurology, Oncology and
Hematology, Immunology, Infertility, Endocrinology, Rheumatology, and Ophthalmology.
Our primary focus is on providing essential medications for patients. We are the second-largest global manufacturer
of Pembrolizumab, Ocrelizumab, Pertuzumab, Omalizumab, and Aflibercept.
In the year 1401 (2022-2023), nearly 780,000 patients have benefited from our medications. Additionally, we have
successfully prevented a significant outflow of funds amounting to 2.7 billion USD through the local production of our
drugs in the same year.
Internationally, we have achieved 11 GMP certifications, executed 8 technology transfer projects, and our products
contribute to 60% of our country’s pharmaceutical exports.
Our achievements signify our unwavering commitment to quality. We ensure the provision of essential medications to
patients, foster hope within them, and actively contribute to the pharmaceutical industry of our country.

Production Lines:
CinnaGen Co. holds a marketing authorization issued from the Iranian MOH for the production, control and the
sale of pharmaceutical products. CinnaGen Co. is focusing on the manufacture of pharmaceutical products, such as
recombinant proteins and peptides.
Production areas are mentioned in the below:
mAb Production Line
CHO Production Line
E. coli Production Line
Formulation and Filling Facility (Vial, Cartridge, Syringe)
Packaging Facility
Certificates:
Philippines Azerbaijan
Russia Sri Lanka
Armenia Europe (EMA)
Turkey Brazil (ANVISA)
Peru (DIGEMID) Pakistan
ISO 9001 ISO 14001
ISO 13485

Therapeutic Groups and Pharmaceuticals with Capacity for Exports :
Neurology: CinnoVex - ReciGen - Xacrel - Cinnomer
Immunology & Rheumatology: CinnoRA - Tylia - Zerafil
Endocrinology & Fertility: Melitide - Maciza - CinnaTropin - Cinnal f
Oncology & Hematology: Ablyze - CinnaStim - Cinnapoietin - PegaGen - ZakAria - Pectuna - CinnaFact - Xtramab
Vaccine: SpikoGen

Target Countries for Exports:
Angola, Armenia, Azerbaijan, Belarus, Bolivia, Brazil, Cambodia, Dominican, Georgia, Honduras, India, Indonesia, Iraq,
Kenya, Kazakhstan, Kyrgyzstan, Lebanon, Mauritius, Moldova, Morocco, Mozambique, Nigeria, Oman, Pakistan, Peru,
Philippines, Russia, Serbia, Singapore, Sri Lanka, Syria, Tajikistan, Turkey, Tunisia, UAE, Uganda, Ukraine, Uzbekistan,
Venezuela, Vietnam, Yemen

28